PerkinElmer Inc (NYSE:PKI)

176.44
Delayed Data
As of Oct 22
 -0.06 / -0.03%
Today’s Change
119.95
Today|||52-Week Range
192.00
+22.95%
Year-to-Date
PKI Regular Dividend: PKI began trading ex-dividend on 10/21/21. A $0.07 dividend will be paid to shareholders of record as of 10/22/21.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Oct 22 / Zacks.com - Paid Partner Content
PerkinElmer's (PKI) New Deal to Improve Single-Cell Profiling
Oct 19 / Zacks.com - Paid Partner Content
PerkinElmer (PKI) Sees Hammer Chart Pattern: Time to Buy?
Oct 22 / Zacks.com - Paid Partner Content
PerkinElmer (PKI) Receives EUA from FDA for Latest Assay
Oct 15 / Zacks.com - Paid Partner Content
Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?
Oct 21 / Zacks.com - Paid Partner Content
BD's (BDX) New Manufacturing Facility to Boost Supply Readiness
Oct 15 / Zacks.com - Paid Partner Content
PKI or MTD: Which Is the Better Value Stock Right Now?
Oct 21 / Zacks.com - Paid Partner Content
BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance
Oct 14 / Zacks.com - Paid Partner Content
Looking for Earnings Beat? Play These 5 Stocks
Oct 21 / Zacks.com - Paid Partner Content
PerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay
Oct 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close176.50
Today’s open176.75
Day’s range175.17 - 178.08
Volume300,405
Average volume (3 months)705,554
Market cap$19.8B
Data as of 4:00pm ET, 10/22/2021

Growth & Valuation

Earnings growth (last year)+217.93%
Earnings growth (this year)+21.36%
Earnings growth (next 5 years)+16.83%
Revenue growth (last year)+31.18%
P/E ratio16.8
Price/Sales4.25
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
BIOBio Rad Laboratories...-6.68-0.88%
WATWaters Corp+3.50+0.97%
QGENQiagen NV+0.50+0.93%
BRKRBruker Corp+0.10+0.13%
Data as of 4:00pm ET, 10/22/2021

Financials

Next reporting dateNovember 3, 2021
EPS forecast (this quarter)$1.74
Annual revenue (last year)$3.8B
Annual profit (last year)$728.1M
Net profit margin19.25%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts